- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04419285
Mobility Protocol Adapted for Advanced Visually Impaired Subjects (PROMA)
Design of a Mobility Protocol to Assess the Impact of Visual Pathologies in Daily Life Activities for Subjects With Advanced Visual Deficits
Retinitis Pigmentosa is characterized by a progressive disappearance of photoreceptors, responsible for a progressive and severe loss of vision.
People Retinitis Pigmentosa therefore encounter a large number of difficulties in daily life, specifically for:
- Visual research
- Visuo-motor coordination in tasks requiring fine motor control
- Visuo-motor coordination in mobility tasks
This study aims to assess the difficulties in the daily life of subjects with Retinitis Pigmentosa at a very advanced stage unsing, quaify of life questionnaires, simplified locomotion tasks in real situation and a posture task.
They are proposing a new test adapted and carried out in real situations, in binocular and monocular vision, making it possible to finely assess locomotion especially for "very low vision" patients.
This test will also ultimately make it possible to better evaluate the effectivements, that is to say to observe and quantify objectively by a score the performance progression obtained for locomotion tasks related to the visual recovery generated by the treatment.
Study Overview
Status
Conditions
Detailed Description
This is monocentric study and the total duration of the study is 48 months. The duration of participation for each research subject is 3 months and maximum 4 visits. This is research involving the human type of non-invasive interventional research, with minimal risks and constraints.
This exploratory study will be conducted on a group of patients with Retinitis Pigmentosa at a very advanced stage.
There will be an inclusion visit including a visual assessment and an ophthalmological consultation. Two experimental visits with tests carried out in a real environment including a locomotion and a posture tasks. An end-of-study visit within a maximum of 1 month following the second experimental visit.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Tania TR RILCY
- Phone Number: +33140021126
- Email: trilcy@15-20.fr
Study Contact Backup
- Name: Hayet HS SERHANE
- Phone Number: +3314021144
- Email: hserhane@15-20.fr
Study Locations
-
-
-
Paris, France, 75012
- Recruiting
- Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
-
Contact:
- Saddek SM MOHAND-SAID, MD
- Phone Number: 01400021421
- Email: smolhand@15-20.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Retinitis Pigmentosa, non-syndromic, the diagnosis of which has been confirmed by an ophtmalmologist
- ETDRS visual acuity less than 2/10 (>+0.7 logMAR; <20/100 Snellen)
- Doesn't participate in clinical research that may interfere with this study
- Sufficient knowledge of the French language to ensure a perfect understanding of the tasks to be performed and the instructions received
- Consent to the study signed after information by the investigator
- Health insurance affiliation
Exclusion Criteria:
- Pregnant women
- Inability to give personal consent
- Cataract surgery in the 3 months preceding inclusion
- Amblyopia
- Inability to comply with the instructions for carrying out the study tasks or to complete the study visits
- MMSE score without visual item ≤ 20/25
- Drug treatment which can lead to motor, visual or cognitive disorders (PSA, neuroleptics,etc.) or which may interfere with the study's evaluations
Study Plan
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Retinitis Pigmentosa patients
50 patients with very severe Retinitis Pigmentosa
|
The locomotion task takes place on a Streetlab platform.
The subject must follow a line on the ground, straight or composed of turns.
Other Names:
The task takes place on a Streetlab platform with uniform walls without decorations in order to remove any localization element.
Other Names:
Study the correlations between the subjects' quality of life scores and the results during behavioral tests.
Identify the subjective parameters most sensitive to sensory-motor performance.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Discriminating
Time Frame: Month 1
|
Study of the correlation between the severity of the impairment with regard to visual evaluations (visual acuity, visual field, ect) and the performance score for locomotion and posture tests.
|
Month 1
|
Reproducibility
Time Frame: Month 1
|
Graphical and tabular representations will be prepared to represent the correlation between test results and visual function measures on the one hand and daily life activities on the other.
|
Month 1
|
Validity of construction
Time Frame: Month 1
|
Graphical and tabular representations will be prepared to represent the correlation between test results and visual function measures on the one hand and daily life activities on the other.
|
Month 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Measurement of postural parameters
Time Frame: Month 1
|
The locomotion task which takes place in a Streetlab platform. The subject must follow a line on the ground, straight or composed of turns. For the other tests, the number of turns and the distance to be covered are identical, but the shapes of the courses are systematically different. The posturology task SOT (Sensory Organization Test) takes place in a StreetLab platform with uniform walls without decorations so as to remove any localization element. The subject is instructed to stand with his hands on his hips as steadily as possible. This test includes 4 experimental conditions for disturbing sensory inputs. the duration of acquisition is 30 seconds, during which the subject must hold a standing position as tatic as possible, without speaking, els hands positioned on the hips while looking straight ahead. Four experimental conditions are tested: Eyes open on a hard floor, eyes closed on a hard floor, eyes open on a foam tray, eyes closed on a foam tray. |
Month 1
|
Collaborators and Investigators
Investigators
- Principal Investigator: Saddek SM MOHAND-SAID, MD, Centre Hospitalier National d'Ophtalmologie des Quinze-Vingts
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P19-04
- 2019-A00937-50 (OTHER: IDRCB Number)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pigmentary Retinopathy
-
University Hospital, Strasbourg, FranceUnknown
-
Janssen Research & Development, LLCCompletedInterstitial Cystitis | Pigmentary Retinopathy | Pigmentary MaculopathyUnited States
-
Centre Hospitalier National d'Ophtalmologie des...Unknown
-
Assiut UniversityUnknownPigmentary Skin Lesions | Dermoscopy
-
Sensimed AGPrivate practicioner, Dr Sunaric Mégevand; Orasis, AugenZentrum PajicTerminatedPigmentary Dispersion Syndrome | Pigmentary Glaucoma PatientsSwitzerland
-
Indiana UniversityRecruitingPigmentary Retinopathy | Pentosan Polysulfate Sodium Maculopathy | Pigmentary Maculopathy | Toxic Maculopathy | Interstitial Cystitis, ChronicUnited States
-
University Hospital, MontpellierIntegraGen SANot yet recruitingPigmentary; Dermatosis
-
Ivantis, Inc.CompletedPrimary Open Angle Glaucoma | Pigmentary Glaucoma | Pseudoexfoliative GlaucomaUnited States
-
Washington University School of MedicineCompletedCentral Serous Retinopathy (CSR)United States
-
Ivantis, Inc.CompletedPrimary Open Angle Glaucoma | Pseudoexfoliative Glaucoma | Pigmentary Dispersion GlaucomaUnited States
Clinical Trials on Locomotion task
-
University of CincinnatiRecruitingStroke | Gait, Hemiplegic | Chronic Stroke | Walking, DifficultyUnited States
-
Centre Hospitalier National d'Ophtalmologie des...Recruiting
-
Istituti Clinici Scientifici Maugeri SpADept. of Electronics, Informatics, Bioengineering, Politecnico di Milano,...RecruitingParkinson Disease | Stroke, Acute | Femur FractureItaly
-
University of SalamancaNot yet recruiting
-
University of CincinnatiAmerican Academy of NeurologyCompletedStroke | Gait, Hemiplegic | Chronic Stroke | Walking, DifficultyUnited States
-
NUMEN FoundationUniversidad Europea de MadridNot yet recruiting
-
Charles University, Czech RepublicCompletedMultiple Sclerosis | Rehabilitation | Neuronal Plasticity
-
Wiktor Dega University Orthopedic and Rehabilitation...Recruiting
-
Yeditepe UniversityRecruitingCybersicknessTurkey
-
Corina EppleCompleted